Karen K. Daniels

All filings by Karen K. Daniels on record concern Adamis Pharmaceuticals Corp. The record holds 13 filings, for trades running from 6 March 2013 to 18 November 2020.

The open-market record consists of 9 sales worth €60k, with no purchase. Other entries cover 3 share grants and 1 option exercise. In 2020 alone, the filings show no purchases and 5 sales.

On 20 November 2020 came the latest disclosure, an open-market sale for €1,826 in Adamis Pharmaceuticals Corp. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.